DE69615400T2 - 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen - Google Patents

5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen

Info

Publication number
DE69615400T2
DE69615400T2 DE69615400T DE69615400T DE69615400T2 DE 69615400 T2 DE69615400 T2 DE 69615400T2 DE 69615400 T DE69615400 T DE 69615400T DE 69615400 T DE69615400 T DE 69615400T DE 69615400 T2 DE69615400 T2 DE 69615400T2
Authority
DE
Germany
Prior art keywords
asa
diseases
colonal
treating
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69615400T
Other languages
English (en)
Other versions
DE69615400T3 (de
DE69615400D1 (de
Inventor
Kluever Jepsen
Soeren Halskov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmaceutisk Laboratorium Ferring AS
Original Assignee
Farmaceutisk Laboratorium Ferring AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69615400(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Farmaceutisk Laboratorium Ferring AS filed Critical Farmaceutisk Laboratorium Ferring AS
Application granted granted Critical
Publication of DE69615400D1 publication Critical patent/DE69615400D1/de
Publication of DE69615400T2 publication Critical patent/DE69615400T2/de
Publication of DE69615400T3 publication Critical patent/DE69615400T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69615400T 1995-12-21 1996-12-23 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen Expired - Lifetime DE69615400T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57595495A 1995-12-21 1995-12-21
US575954 1995-12-21
PCT/DK1996/000551 WO1997023199A1 (en) 1995-12-21 1996-12-23 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases

Publications (3)

Publication Number Publication Date
DE69615400D1 DE69615400D1 (de) 2001-10-25
DE69615400T2 true DE69615400T2 (de) 2002-05-23
DE69615400T3 DE69615400T3 (de) 2008-08-07

Family

ID=24302375

Family Applications (2)

Application Number Title Priority Date Filing Date
DE0871434T Pending DE871434T1 (de) 1995-12-21 1996-12-23 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen
DE69615400T Expired - Lifetime DE69615400T3 (de) 1995-12-21 1996-12-23 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE0871434T Pending DE871434T1 (de) 1995-12-21 1996-12-23 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen

Country Status (28)

Country Link
EP (1) EP0871434B2 (de)
JP (1) JP4714836B2 (de)
KR (2) KR100598714B1 (de)
CN (1) CN1155369C (de)
AT (1) ATE205704T1 (de)
AU (1) AU702934B2 (de)
BG (1) BG63484B1 (de)
BR (1) BR9612213A (de)
CA (1) CA2240281C (de)
CZ (1) CZ289290B6 (de)
DE (2) DE871434T1 (de)
DK (1) DK0871434T4 (de)
EE (1) EE03740B1 (de)
ES (1) ES2149733T5 (de)
HK (1) HK1017615A1 (de)
HU (1) HU228856B1 (de)
IL (1) IL124858A (de)
IS (1) IS1834B (de)
NO (1) NO320498B1 (de)
NZ (1) NZ325201A (de)
PL (1) PL186790B1 (de)
PT (1) PT871434E (de)
RU (1) RU2181043C2 (de)
SI (1) SI0871434T2 (de)
SK (1) SK282669B6 (de)
TR (1) TR199801158T2 (de)
UA (1) UA67721C2 (de)
WO (1) WO1997023199A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
WO2000044353A1 (de) 1999-01-29 2000-08-03 Losan Pharma Gmbh Pharmazeutische zusammensetzungen
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
JP4726414B2 (ja) * 2001-10-15 2011-07-20 フェリング ベスローテン フェンノートシャップ 潰瘍性大腸炎およびクローン病の治療に使用するための５−アミノサリチル酸を含む医薬組成物の調製方法
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
EP1615619A2 (de) * 2003-04-23 2006-01-18 Ferring B.V. Sachet für pharmazeutische zubereitungen
EP1547601A1 (de) 2003-12-23 2005-06-29 Ferring B.V. Beschichtungsverfahren
RU2297835C1 (ru) 2005-09-26 2007-04-27 Закрытое акционерное общество "Партнер" Препарат для лечения неинфекционных воспалительных болезней кишечника
KR101333753B1 (ko) * 2006-04-13 2013-11-28 주식회사 아라온테크 세포 손상 및 염증 질환의 치료 또는 예방용 약학 조성물
EP2328549B1 (de) * 2008-08-22 2017-11-15 Reckitt Benckiser Healthcare (UK) Limited Zusammensetzungen gegen halsschmerzen
EP2334178A4 (de) 2008-10-03 2012-04-11 Falk Pharma Gmbh Zusammensetzungen und verfahren zur behandlung von darmerkrankungen mit granuliertem mesalamin
EP2340812A1 (de) 2009-12-18 2011-07-06 Ferring International Center S.A. Granulat für pharmazeutische Präparate sowie Verfahren und Vorrichtungen zu ihrer Herstellung
RU2463055C2 (ru) * 2011-01-12 2012-10-10 Петр Леонидович Щербаков Способ лечения воспалительных заболеваний кишечника
CN102319218B (zh) * 2011-09-22 2014-10-01 贝沃特医药技术(上海)有限公司 一种治疗肠道疾病的药物缓控释微粒制剂及其制备方法
WO2013144176A1 (en) 2012-03-30 2013-10-03 Laboratorios Del Dr. Esteve, S.A. Controlled release formulatin comprising mesalamine
RU2752082C1 (ru) * 2020-09-29 2021-07-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство с гранулами, содержащими 5-аминосалициловую кислоту и фолиевую кислоту, с контролируемым высвобождением

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57500432A (de) * 1980-03-20 1982-03-11
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
SK83498A3 (en) 1999-01-11
EP0871434B2 (de) 2007-12-12
CA2240281A1 (en) 1997-07-03
IS1834B (is) 2002-11-15
WO1997023199A1 (en) 1997-07-03
CN1155369C (zh) 2004-06-30
DK0871434T4 (da) 2008-04-07
DE871434T1 (de) 2001-04-05
CZ289290B6 (cs) 2001-12-12
CN1207672A (zh) 1999-02-10
PL327323A1 (en) 1998-12-07
BR9612213A (pt) 1999-12-28
AU702934B2 (en) 1999-03-11
BG63484B1 (bg) 2002-03-29
EE03740B1 (et) 2002-06-17
DE69615400T3 (de) 2008-08-07
IL124858A0 (en) 1999-01-26
EP0871434B1 (de) 2001-09-19
HU228856B1 (en) 2013-06-28
ES2149733T3 (es) 2002-04-01
CA2240281C (en) 2007-02-27
NO320498B1 (no) 2005-12-12
PT871434E (pt) 2002-02-28
ES2149733T1 (es) 2000-11-16
TR199801158T2 (xx) 1998-09-21
NO982904L (no) 1998-06-22
AU1366197A (en) 1997-07-17
JP4714836B2 (ja) 2011-06-29
EE9800191A (et) 1998-12-15
PL186790B1 (pl) 2004-02-27
EP0871434A1 (de) 1998-10-21
JPH11510191A (ja) 1999-09-07
IS4772A (is) 1998-06-15
DE69615400D1 (de) 2001-10-25
SK282669B6 (sk) 2002-11-06
NZ325201A (en) 1998-11-25
ATE205704T1 (de) 2001-10-15
KR20050087886A (ko) 2005-08-31
BG102556A (en) 1999-02-26
SI0871434T1 (en) 2002-04-30
HUP0001084A3 (en) 2000-12-28
IL124858A (en) 2003-03-12
UA67721C2 (en) 2004-07-15
KR100598714B1 (ko) 2006-07-10
HUP0001084A2 (hu) 2000-11-28
DK0871434T3 (da) 2002-01-07
CZ194698A3 (cs) 1998-10-14
ES2149733T5 (es) 2008-05-01
SI0871434T2 (sl) 2008-04-30
KR100542544B1 (ko) 2006-05-10
NO982904D0 (no) 1998-06-22
HK1017615A1 (en) 1999-11-26
KR19990076584A (ko) 1999-10-15
RU2181043C2 (ru) 2002-04-10

Similar Documents

Publication Publication Date Title
DE69615400T2 (de) 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen
RU95109905A (ru) Композиции в жидком, полутвердом, твердом, гелеобразном или пастообразном виде и способ лечения заболеваний полости рта
DE69634693D1 (de) Mehrfach ungesättigte omega-3 fettsäuren zur behandlung von entzündlichen darmerkrankungen in kapseln mit zeitabhängiger freisetzung
DE69634776D1 (de) Verwendung eines r-nsaid als chemoschützendes mittel zur behandlung kolorektales krebs
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
DE69720985D1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
DE60138547D1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
DE69025271D1 (de) Pharmazeutische Zubereitungen mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen
DK0497956T3 (da) Præparater med reguleret frigivelse
DE69632396D1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
DE59002748D1 (de) Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
MX9806188A (es) Derivados de acidos benzofurano-acrilicos y su utilizacion como moduladores de los receptores rxrs o rars.
ATE285252T1 (de) Mittel zur verhinderung der truebung der vorderen linsenkapsel
ATE22282T1 (de) Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8328 Change in the person/name/address of the agent

Representative=s name: HOFFMANN & EITLE, 81925 MUENCHEN